Home > Financial Ratios > SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
SUVEN PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
AD     Remove this Ad

SUVEN PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 68.0536.8019.3923.4127.87

What is the latest EV/Core EBITDA ratio of SUVEN PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of SUVEN PHARMACEUTICALS is 68.05 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202568.05
Mar202436.80
Mar202319.39
Mar202223.41
Mar202127.87

How is EV/Core EBITDA of SUVEN PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 68.05
84.92
Mar2024 36.8
89.79
Mar2023 19.39
-17.17
Mar2022 23.41
-16.00
Mar2021 27.87 -

Other Financial Ratios of SUVEN PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of SUVEN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS ₹11,497.1 Cr -0.1% -0.6% -72.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,326.0 Cr -5.7% -3.3% -2.1% Stock Analytics
DIVIS LABORATORIES ₹155,282.0 Cr -3.1% -9.3% 0% Stock Analytics
TORRENT PHARMACEUTICALS ₹137,043.0 Cr -6.1% -8.3% 23.7% Stock Analytics
DR REDDYS LABORATORIES ₹99,854.2 Cr -5.1% -6% 4.8% Stock Analytics
CIPLA ₹97,115.7 Cr -3.3% -11.2% -19.5% Stock Analytics


SUVEN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS

-0.1%

-0.6%

-72.3%

SENSEX

1.4%

-7%

-3.9%


You may also like the below Video Courses